Details of the Researcher

PHOTO

Asami Nakayama
Section
Graduate School of Medicine
Job title
Assistant Professor
Degree

  • Ph.D (Nagasaki University)

Research History 7

  • 2024/10 - Present
    東北大学大学院医学系研究科 内科病態学講座 総合感染症学分野

  • 2024/10 - Present
    東北大学病院 診療技術部臨床検査部門（兼任）

  • 2026/05 - 2026/07
    Rush University Medical Center　Department of Infectious Disease

  • 2021/01 - 2024/09
    東北大学病院 診療技術部臨床検査部門

  • 2018/04 - 2020/12
    山形大学医学部附属病院 検査部

  • 2013/04 - 2018/03
    岐阜大学医学部附属病院 検査部

  • 2006/04 - 2013/03
    藤田医科大学病院（藤田保健衛生大学病院） 臨床検査部

Show all Show first 5

Research Areas 1

  • Life sciences / Bacteriology / Clinical Microbiology

Papers 24

  1. Development and validation of a machine learning model for predicting positive blood cultures using vital signs in ICU patients. International-journal

    Issei Seike, Hiroaki Baba, Shinya Sonobe, Junya Iwazaki, Makoto Miyauchi, Tomoya Kobayashi, Eichi Takaya, Saori Ikumi, Taro Miyamoto, Shota Kawamoto, Shintaro Oyama, Takahiro Imaizumi, Akemi Morohashi, Kengo Oshima, Asami Nakayama, Tetsuji Aoyagi

    Scientific reports　16　(1)　2026/04/24

    DOI： 10.1038/s41598-026-50400-w 　

    More details Close

    Bloodstream infections require timely and appropriate diagnosis and treatment, as inadequate management is associated with higher mortality. Previous predictive models for bloodstream infection have generally incorporated laboratory test results in addition to vital signs, although laboratory results are not always immediately available in clinical practice. This study aimed to develop and validate a machine learning model to predict positive blood cultures using only vital signs in febrile intensive care unit (ICU) patients (maximum BT ≥ 38 °C). Clinical data from ICU patients at two university hospitals were included, with 597 blood cultures used for model development and 366 for external validation. Six explanatory variables derived from body temperature, heart rate, and mean arterial pressure measured over three days were used to construct a Balanced Random Forest model. The area under the receiver operating characteristic curve was 0.700 ± 0.072 for internal validation and 0.679 ± 0.010 for external validation. SHapley Additive exPlanations value analysis indicated that a larger temperature range contributed to positive predictions, while no increase in temperature, increases in blood pressure, and a decrease in heart rate contributed to negative predictions. The model demonstrates moderate predictive performance and shows comparable results across different datasets. It can continuously monitor the need for blood cultures, thereby serving as an adjunctive tool to support clinical decision-making.

  2. 臨床微生物検査におけるTurnaround time(TAT)モニタリングの有用性と質評価指標としての適用可能性の検討

    中山 麻美, 千葉 美紀子, 星 啓太, 石戸谷 真帆, 佐藤 敦子, 大杉 悠平, 木村 裕子, 佐々木 克幸, 勝見 真琴, 菅原 新吾, 青柳 哲史

    日本臨床微生物学会雑誌　36　(1)　25-30　2025/12

    Publisher: (一社)日本臨床微生物学会

    ISSN： 2434-866X

  3. High-risk clonal expansion of IMP-producing Enterobacter cloacae complex in regional Japanese healthcare settings

    Kentarou Takei, Hajime Kanamori, Ryuji Sakata, Miho Ogawa, Hiroaki Baba, Yumiko Takei, Asami Nakayama, Tetsuji Aoyagi

    Antimicrobial Agents and Chemotherapy　2025/10/17

    Publisher: American Society for Microbiology

    DOI： 10.1128/aac.00953-25 　

    ISSN： 0066-4804

    eISSN： 1098-6596

    More details Close

    ABSTRACT Carbapenemase-producing Enterobacter cloacae complex (CPEC) represents an emerging threat in healthcare settings; however, its spread across local and regional hospitals remains elusive. Between 2014 and 2022, 211 non-duplicate E. cloacae complex isolates (ECC) with reduced carbapenem susceptibility based on automated susceptibility testing were collected from 58 hospitals in 14 prefectures across Japan. PCR detected the bla IMP-1 group in 92.9% of isolates. Among these, 80 representative CPEC isolates underwent whole-genome sequencing. Two dominant high-risk clonal groups, ST78 and ST133 (including single-locus variants), accounted for 62.5% of sequenced isolates. Notably, ST133—rarely reported in Japan—was the second most common type and detected widely, suggesting gradual and inconspicuous dissemination. ST78 exhibited substantial genomic diversity, frequent co-carriage of extended-spectrum beta-lactamase genes, and multiple plasmid replicons, while ST133 formed a more uniform lineage with limited resistance determinants. Most isolates remained highly susceptible to amikacin and cefiderocol. Core-genome multi-locus sequence typing suggested possible intra-facility persistence and inter-facility transmission of closely related strains (≤10 allele differences) in some hospitals over time. Among the 46 facilities with bla IMP-1 group-positive isolates, 73.9% (34/46) were small hospitals (<200 beds). The proportion among screened ECC isolates was similarly high in small and large hospitals (90.5% vs 94.8%), with no significant difference, suggesting the need to extend molecular surveillance even in resource-limited settings. These findings highlight the utility of molecular confirmation and targeted genomic analysis, particularly in regions or settings where high-risk CPEC clones may circulate undetected, to support timely detection and containment efforts.

  4. Validation of the United States isolation termination criteria using virus culture results of the omicron variant in Japan. International-journal

    Issei Seike, Hiroaki Baba, Michiko Okamoto, Asami Nakayama, Tetsuji Aoyagi

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy　31　(6)　102714-102714　2025/06

    DOI： 10.1016/j.jiac.2025.102714 　

    More details Close

    Cycle threshold (Ct) values obtained from real-time reverse-transcription polymerase chain reaction (RT-PCR) tests are commonly used to determine COVID-19 isolation discharge from hospitals. However, not all patients with low Ct values are infectious, and studies evaluating infectivity through virus cultures in Japan remain limited. This study assessed patients with Ct values <30 at 10 days after symptom onset and compared the clinical characteristics of seven patients with positive virus culture results and 11 patients with negative virus culture results to validate the Centers for Disease Control and Prevention (CDC) isolation criteria in Japan. Among non-immunosuppressed patients with mild-to-moderate COVID-19, 80 % were virus culture-negative 10 days after symptom onset, even when the Ct values were <30. In contrast, only 33 % of patients with severe-to-critical symptoms tested negative on virus culture. All immunosuppressed patients with severe-to-critical symptoms consistently tested positive in virus cultures. Notably, three patients with hematological disorders remained virus culture-positive 20 days after symptom onset. These findings generally align with the CDC criteria. For non-immunosuppressed patients with mild-to-moderate COVID-19, isolation release after 10 days is supported without the need for additional RT-PCR testing. However, for non-immunosuppressed patients with severe-to-critical symptoms and immunocompromised patients, particularly those with hematological disorders, isolation may be safely discontinued when Ct values exceed 30 after 10 days. This study provides valuable insights into identifying individuals suitable for isolation release based on SARS-CoV-2 testing in Japan.

  5. Evaluation of MALDI-TOF mass spectrometry coupled with ClinProTools as a rapid tool for toxin-producing Clostridioides difficile. International-journal

    Asami Nakayama, Yoshitomo Morinaga, Ryota Izuno, Keita Morikane, Katsunori Yanagihara

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy　30　(9)　847-852　2024/09

    DOI： 10.1016/j.jiac.2024.02.024 　

    More details Close

    INTRODUCTION: The performance of MALDI-TOF MS combined with analysis platform for identification of toxin-producing Clostridiodes difficile is yet to be known. METHODS: Between August 2018 and September 2020, 61 isolates from stool specimens of patients with C. difficile-associated diarrhea were analyzed using the MALDI Biotyper system. A C. difficile toxin-producer detection model was developed using ClinProTools. The model was validated using 28 known strains that differed from the isolates used to develop the model. RESULTS: The sensitivity and specificity of the Genetic Algorithm (GA) model using isolates grown on Brucella with hemin and vitamin K (BHK) agar plates were 91.7% and 44.4%, respectively. When isolates grown on cycloserine-cefoxitin mannitol agar were analyzed by the model, sensitivity and specificity were 6.3% and 100%, respectively. The GA model using BHK medium showed the highest discriminatory performance in detection of toxin-producing C. difficile. However, a discrepancy in detection of toxin-producing C. difficile was observed in the results generated when the model was being developed and when the model was validated which suggests that incubation conditions may have affected the results. CONCLUSION: MALDI-TOF analysis using ClinProTools has a potential to be a cost-effective tool for rapid diagnosis and contribute to antimicrobial stewardship by differentiating toxin-producing C. difficile from non-producers.

  6. A cluster of Candida parapsilosis displaying fluconazole-trailing in a neonatal intensive care unit successfully contained by multiple infection-control interventions. International-journal

    Hiroaki Baba, Hajime Kanamori, Asami Nakayama, Takami Sato, Makoto Katsumi, Takae Chida, Shinobu Ikeda, Rio Seki, Teppei Arai, Katsuhiko Kamei, Koichi Tokuda

    Antimicrobial stewardship & healthcare epidemiology : ASHE　4　(1)　e86　2024

    DOI： 10.1017/ash.2024.77 　

    More details Close

    OBJECTIVE: This study aimed to investigate and contain a cluster of invasive candidiasis cases caused by fluconazole-resistant Candida parapsilosis (FRC) in a neonatal intensive care unit. METHODS: Active surveillance was initiated. Direct observations of hand-hygiene compliance (HHC) among staff were conducted before and after the implementation of hand-hygiene (HH) education. Thirty-five environmental cultures were obtained. Phylogenetic analysis of FRC was performed using Fourier-transform infrared spectroscopy and microsatellite genotyping. RESULTS: A total of 14 patients (mean birth weight = 860 g, gestational age = 25 weeks) infected with FRC were identified using the fully automated analyzer, including 5 with clinical infection (three with catheter-related bloodstream infection, one with cutaneous infection, and one with fatal peritonitis) and 9 with colonization. The HHC rate in nurses before performing a sterile or aseptic procedure significantly improved after the HH education (P < .05). Sinks near the patients were contaminated with FRC. All FRC strains were confirmed to be susceptible to fluconazole using the CLSI method, and the microdilution procedure indicated a trailing effect. Phylogenetic analysis showed that all the fluconazole-trailing isolates from patients were clustered together and had the same genotype. Sinks were successfully decontaminated using accelerated hydrogen peroxide and drainage pipes were replaced. Ultraviolet-C decontamination was applied in the milk preparation room. No new cases were detected after the education and disinfection interventions. CONCLUSIONS: Sinks are an important reservoir of C. parapsilosis. Active surveillance, environmental hygiene, and constant staff education on maintaining a high level of HHC are necessary to limit the spread of C. parapsilosis.

  7. Severe pneumonia due to Legionella and SARS-CoV-2 co-infection necessitating medical evacuation from a cargo ship. International-journal

    Shiori Kitaya, Hiroaki Baba, Michiko Okamoto, Masahiro Sakamoto, Asami Nakayama, Yumiko Takei, Issei Seike, Kentarou Takei, Kengo Oshima, Koichi Tokuda, Takuya Shiga, Hajime Kanamori

    Journal of travel medicine　30　(5)　2023/09/05

    DOI： 10.1093/jtm/taad067 　

  8. Screening for Metallo-Beta-Lactamases Using Non-Carbapenem Agents: Effective Detection of MBL-Producing Enterobacterales and Differentiation of Carbapenem-Resistant Enterobacterales. International-journal

    Kentarou Takei, Hajime Kanamori, Asami Nakayama, Mikiko Chiba, Yumiko Takei, Issei Seike, Chiho Kitamura, Hiroaki Baba, Kengo Oshima, Koichi Tokuda

    Antibiotics (Basel, Switzerland)　12　(7)　2023/07/03

    DOI： 10.3390/antibiotics12071146 　

    More details Close

    Metallo-beta-lactamases (MBLs) are enzymes that break down carbapenem antibiotics, leading to carbapenem-resistant organisms. Carbapenemase-resistant Enterobacterales (CRE) is one of them. Outbreaks of CRE infection can occur in healthcare facilities and lead to increased deaths, illness, and medical costs. This study was conducted to detect MBLs using non-carbapenem agents and exclude MBLs among CRE isolates. A total of 3776 non-duplicate sequential Enterobacterales isolates from a single facility were screened between January 2019 and December 2022 using non-carbapenem agents, ceftazidime and cefoperazone/sulbactam. Positive 153 isolates (4.0%) were further tested using carbapenemase-confirmation tests and verified through polymerase chain reaction (PCR) testing. Fifteen imipenemase (IMP)-type MBL-producing Enterobacterales (0.4%) including one susceptible to carbapenems were identified. Moreover, 160 isolates (4.2%) meeting the criteria for CRE were directly subjected to PCR testing. All fourteen CRE isolates with MBLs identified through PCR testing were found to be the same strains screened using ceftazidime and cefoperazone/sulbactam. Screening using ceftazidime and cefoperazone/sulbactam can effectively detect MBL-producing Enterobacterales strains. This screening method showed comparable results to screening with meropenem, potentially serving as a supplementary approach and contributing to differentiating between MBL- and non-MBL-producing CRE strains. Our findings support these screening methods, particularly in regions where IMP-type MBLs are prevalent.

  9. Rapid Detection of SARS-CoV-2 RNA Using Reverse Transcription Recombinase Polymerase Amplification (RT-RPA) with Lateral Flow for N-Protein Gene and Variant-Specific Deletion-Insertion Mutation in S-Protein Gene. International-journal

    Jose L Malaga, Monica J Pajuelo, Michiko Okamoto, Emmanuel Kagning Tsinda, Kanako Otani, Pablo Tsukayama, Lucero Mascaro, Diego Cuicapuza, Masamichi Katsumi, Kazuhisa Kawamura, Hidekazu Nishimura, Akie Sakagami, Yo Ueki, Suguru Omiya, Satoshi Okamoto, Asami Nakayama, Shin-Ichi Fujimaki, Chuyao Yu, Sikandar Azam, Eiichi Kodama, Clyde Dapat, Hitoshi Oshitani, Mayuko Saito

    Viruses　15　(6)　2023/05/26

    DOI： 10.3390/v15061254 　

    More details Close

    Rapid molecular testing for severe acute respiratory coronavirus 2 (SARS-CoV-2) variants may contribute to the development of public health measures, particularly in resource-limited areas. Reverse transcription recombinase polymerase amplification using a lateral flow assay (RT-RPA-LF) allows rapid RNA detection without thermal cyclers. In this study, we developed two assays to detect SARS-CoV-2 nucleocapsid (N) gene and Omicron BA.1 spike (S) gene-specific deletion-insertion mutations (del211/ins214). Both tests had a detection limit of 10 copies/µL in vitro and the detection time was approximately 35 min from incubation to detection. The sensitivities of SARS-CoV-2 (N) RT-RPA-LF by viral load categories were 100% for clinical samples with high (>9015.7 copies/µL, cycle quantification (Cq): < 25) and moderate (385.5-9015.7 copies/µL, Cq: 25-29.9) viral load, 83.3% for low (16.5-385.5 copies/µL, Cq: 30-34.9), and 14.3% for very low (<16.5 copies/µL, Cq: 35-40). The sensitivities of the Omicron BA.1 (S) RT-RPA-LF were 94.9%, 78%, 23.8%, and 0%, respectively, and the specificity against non-BA.1 SARS-CoV-2-positive samples was 96%. The assays seemed more sensitive than rapid antigen detection in moderate viral load samples. Although implementation in resource-limited settings requires additional improvements, deletion-insertion mutations were successfully detected by the RT-RPA-LF technique.

  10. 3ステップアルゴリズム法におけるClostridioides difficile Toxin検出試薬の有用性評価—Evaluation of the usefulness of reagents for detecting Clostridioides difficile Toxin in a 3-step algorithmic method

    千葉 美紀子, 中山 麻美, 三浦 悠理子, 勝見 真琴, 阿部 裕子, 藤巻 慎一, 藤原 亨

    日本臨床微生物学会雑誌 = The journal of the Japanese Society for Clinical Microbiology　33　(2)　109-115　2023

    Publisher: 東京 : 日本臨床微生物学会

    ISSN： 2434-866X

  11. Evaluation of presumptive identification of Enterobacterales using CHROMagar Orientation medium and rapid biochemical tests. International-journal

    Hirofumi Ohtaki, Akifumi Takahashi, Ayumi Niwa, Jun Yonetamari, Asami Nakayama, Tomokazu Kuchibiro, Hirotoshi Ohta, Hiroyasu Ito, Hisashi Baba, Nobuo Murakami, Kiyofumi Ohkusu

    Journal of clinical laboratory analysis　34　(10)　e23453　2020/10

    DOI： 10.1002/jcla.23453 　

    More details Close

    BACKGROUND: The use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry is gradually spreading among large-scale laboratories; however, this method is impractical for small-scale laboratories. In laboratories without access to these rapid identification methods, problems related to them remain unsolved. In this study, we aimed to develop a rapid and inexpensive method to presumptively identify Enterobacterales using CHROMagar Orientation medium. METHODS: The algorithm for presumptive identification of Enterobacteriaceae using CHROMagar Orientation medium was based on our previous studies. Modified property tests for indole, lysine decarboxylase, ornithine decarboxylase, and hydrogen sulfide were performed to evaluate the differentiation of the bacterial species. RESULTS: Using the type strains and clinical isolates, it was possible to conduct the property tests at a low cost, within 4 hours. The spot indole test was performed without any nonspecific reactions for the bacteria forming colored colonies. The presumptive identification of bacteria was thereby possible within 24 hours after specimen submission. CONCLUSION: All these results suggest that the rapid presumptive identification of Enterobacterales is possible with this new identification method using CHROMagar Orientation medium. This is therefore a prompt and economical method that can be used in routine laboratory work.

  12. Moraxella species: infectious microbes identified by use of time-of-flight mass spectrometry.

    Shunsuke Takahashi, Kazuhiro Murata, Kenji Ozawa, Hiroki Yamada, Hideaki Kawakami, Asami Nakayama, Yuko Asano, Kiyofumi Mochizuki, Hiroshige Mikamo

    Japanese journal of ophthalmology　63　(4)　328-336　2019/07

    DOI： 10.1007/s10384-019-00669-4 　

    More details Close

    PURPOSE: To report the clinical manifestations, identification, antimicrobial susceptibilities, and treatment outcomes of ocular infections caused by Moraxella species. STUDY DESIGN: Retrospective study. PATIENTS AND METHODS: The medical records of all patients treated at the Departments of Ophthalmology of the Ogaki Municipal Hospital and the Gifu University Graduate School of Medicine for ocular infections caused by Moraxella species between January 2011 and June 2017 were examined. The stored Moraxella species isolated from ocular samples were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), molecular identification, and the biochemical properties. RESULTS: Sixteen eyes of 16 patients were treated for Moraxella ocular infections. The patients' median age was 72 years. A predisposing systemic or ocular condition was identified in 15 of the patients. Nine of the patients developed keratitis; four, conjunctivitis; and three, blebitis. M lacunata (6 eyes), M catarrhalis (6), M nonliquefaciens (3), and M osloensis (1) were identified by MALDI-TOF MS. All isolates were sensitive to levofloxacin, tobramycin, ceftazidime, ceftriaxone, and cefazolin. Twelve patients with keratitis or blebitis were treated with various topical antimicrobial combinations, and systemic antibiotics were used in 10 of the 12 patients. The mean time for the complete closure of the epithelial defects with keratitis was 24 days. The visual outcomes after treatment were favorable except in 1 keratitis patient who underwent enucleation. CONCLUSIONS: The use of duo-therapy with a combination of fluoroquinolone and cefmenoxime should be considered in cases nonresponsive to monotherapy, such as keratitis and bleb-associated infections. MALDI-TOF MS is useful for the identification of Moraxella to the species level.

  13. 症例報告 消化器症状を認めなかった患者に発症したCampylobacter jejuni subsp. jejuniによる菌血症の1例—A case of Campylobacter jejuni subsp. jejuni bacteremia without gastrointestinal symptoms

    丹羽 麻由美, 中山 麻美, 北川 順一, 太田 浩敏, 古田 伸行, 伊藤 弘康, 村上 啓雄, 大楠 清文, 清島 満

    日本臨床微生物学雑誌 = The journal of the Japanese Society for Clinical Microbiology　28　(1)　48-53　2018

    Publisher: 東京 : 日本臨床微生物学会

    ISSN： 0917-5059

  14. Case of late-onset bleb associated endophthalmitis caused by Rothia mucilaginosa. International-journal

    Shinya Oie, Kiyofumi Mochizuki, Kyoko Ishida, Asami Nakayama, Kiyofumi Ohkusu

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy　22　(9)　645-7　2016/09

    DOI： 10.1016/j.jiac.2016.02.007 　

    More details Close

    Rothia mucilaginosa is a gram-positive coagulase-negative coccus of the family Micrococcaceae. Although R. mucilaginosa forms part of the oropharyngeal microflora, it has only recently been isolated in ocular infections. We report a case of a 41-year-old man who developed late-onset bleb-related endophthalmitis (BRE). He had undergone glaucoma surgery 21 years earlier and had a thin-walled cystic bleb prior to the development of endophthalmitis in his right eye. He immediately received intravitreal injections of ceftazidime and vancomycin, topical levofloxacin and cefmenoxime, and intravenous cefozopran. Culture of the aqueous humor specimen identified R. mucilaginosa by 16S rRNA sequence analysis. To our knowledge, this is the first report of late-onset BRE caused by R. mucilaginosa. Our case indicates that R. mucilaginosa can be a cause of late-onset BRE, and that molecular analysis is an accurate method to identify R. mucilaginosa.

  15. Recurrent superficial cellulitis-like erythema associated with Helicobacter cinaedi bacteremia. International-journal

    Yuko Adachi, Chie Moriya, Tomomi Fujisawa, En Shu, Hiroyuki Kanoh, Asami Nakayama, Jun Yonetamari, Mariko Seishima

    The Journal of dermatology　43　(7)　844-6　2016/07

    DOI： 10.1111/1346-8138.13282 　

  16. Daily Review of Antimicrobial Use Facilitates the Early Optimization of Antimicrobial Therapy and Improves Clinical Outcomes of Patients with Bloodstream Infections.

    Takashi Niwa, Tamayo Watanabe, Takayuki Goto, Hirotoshi Ohta, Asami Nakayama, Keiko Suzuki, Yasutaka Shinoda, Mayumi Tsuchiya, Koji Yasuda, Nobuo Murakami, Yoshinori Itoh

    Biological & pharmaceutical bulletin　39　(5)　721-7　2016/05/01

    DOI： 10.1248/bpb.b15-00797 　

    More details Close

    Insufficient information is available to confirm the beneficial effects of implementing an antimicrobial stewardship program in reducing mortality of patients with bloodstream infections. A single institutional cohort study was conducted to evaluate clinical outcomes after implementation of a daily review of antimicrobials used to treat patients with bloodstream infections. Subjects were allocated to groups receiving either intervention or nonintervention. After implementation of an antimicrobial stewardship program, the day from the onset of infection required to administer effective intravenous antimicrobial treatment was significantly shortened (p=0.022), and the rate of de-escalation was significantly elevated (p<0.001) compared with the nonintervention group. Further, the rate of 30-d death associated with bloodstream infection was siginificantly reduced from 11.4 to 5.4% (p=0.030) compared with the nonintervention group. The incidence of adverse events was significantly lower in the intervention group than in the nonintervention group (7.7 vs. 28.0%, p<0.001). Our present findings suggest that daily review of the use of antimicrobials was highly effective for optimizing early antimicrobial therapy and improved clinical outcomes of patients with bloodstream infections.

  17. 滞日東ティモール人にみられた多菌型ハンセン病の1例

    水野雄貴, 伊藤満, 周円, 中山麻美, 山内雅裕, 石井則久, 清島真理子

    皮膚科の臨床　58　(13)　2016

    ISSN： 0018-1404

  18. クロモアガーオリエンタシオン/ESBL分画培地を用いたグラム陰性悍菌の簡易同定法とESBL産生菌の効率的な検出法の評価 : 質量分析法との同定精度の比較と費用対効果を含めた検討—Accuracy and Cost-Effectiveness of the CHROMagar Orientation/ESBL medium for Identification and Detection of Extended-Spectrum β-Lactamase (ESBL)-Producing Gram-Negative Bacilli in Comparison to Conventional Methodology and Mass Spectrometry

    中山 麻美, 大瀧 博文, 大楠 清文

    日本臨床微生物学雑誌 = The journal of the Japanese Society for Clinical Microbiology　25　(4)　304-313　2015

    Publisher: 東京 : 日本臨床微生物学会

    ISSN： 0917-5059

  19. A case of bacteremia caused by Leptotrichia trevisanii in a patient with multiple myeloma

    米玉利準, 大瀧博文, 中山麻美, 安藤航平, 宮崎崇, 太田浩敏, 古田伸行, 渡邉珠代, 兼村信宏, 伊藤弘康, 大楠清文, 村上啓雄, 清島満

    日本臨床微生物学雑誌　24　(3)　201-206　2014

    Publisher:

    ISSN： 0917-5059

  20. Moraxella lacunata infection associated with septicemia, endocarditis, and bilateral septic arthritis in a patient undergoing hemodialysis: a case report and review of the literature. International-journal

    Asami Nakayama, Katsuo Yamanaka, Hiroki Hayashi, Kiyofumi Ohkusu

    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy　20　(1)　61-4　2014/01

    DOI： 10.1016/j.jiac.2013.06.002 　

    More details Close

    We report the first case of both endocarditis and bilateral septic arthritis in a patient caused by Moraxella lacunata and successful management of the infection with antimicrobial therapy. The route of entry leading to bacteremia may have been the oral cavity given the poor oral hygiene of the patient as evidenced by bleeding gums. We hypothesize that the bacteremia led to septic arthritis and mitral valve infective endocarditis. In this case report, we also review the literature on M. lacunata infections and conclude that this organism should be considered in bilateral septic arthritis in a patient with underlying heart abnormalities and/or with renal failure.

  21. [A retrospective study of the relationship between bacterial numbers from central venous catheter tip cultures and blood cultures for evaluating central line-associated bloodstream infections].

    Hirofumi Ohtaki, Kiyofumi Ohkusu, Asami Nakayama, Jun Yonetamari, Kohei Ando, Takashi Miyazaki, Hirotoshi Ohta, Nobuyuki Furuta, Tamayo Watanabe, Hiroyasu Ito, Nobuo Murakami, Mitsuru Seishima

    Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology　24　(2)　39-43　2014

    ISSN： 0915-1753

    More details Close

    Catheter-related bloodstream infection (CRBSI) is an infectious disease requiring special attention. It is a common cause of nosocomial infections; catheter insertion into the central veins particularly increases the risk of infection (CLA-BSI: central line-associated bloodstream infection). We examined the relationship between the number of bacterial colonies cultured from shredded central venous catheter (CVC) tips and from blood cultures in our hospital from 2011 to 2012. Coagulase-negative staphylococci topped the list of microbe isolated from the CVC tip culture, followed by Pseudomonas aeruginosa, Staphylococcus aureus, and Candida spp. S. aureus and Candida spp., with growth of over 15 colony-forming units in the CVC tip culture, were also detected at high rates in the blood culture. However, gramnegative bacilli (Enterobacteriaceae and P. aeruginosa) did not show a similar increase in colony number in the CVC tip culture. Because microbes adhering to shredded catheter tips are readily detected by culture, this method is useful as a routine diagnostic test. In addition, prompt clinical reporting of the bacterial number of serious CLA-BSI-causing S. aureus and Candida spp. isolated from CVC tips could contribute to earlier CLA-BSI diagnosis.

  22. A case of sepsis and meningitis caused by probable travel-related Neisseria meningitidis serogroup B infection: the first report of N. meningitidis ST-4893 in Japan.

    Asami Nakayama, Hideyuki Takahashi, Kiyofumi Ohkusa, Katsuo Yamanaka, Chiyo Shintani, Satoshi Hayakawa, Junichi Ishii, Haruo Watanabe

    Japanese journal of infectious diseases　64　(1)　61-2　2011

    eISSN： 1884-2836

    More details Close

    Herein we present a case of Neisseria meningitidis-related sepsis and meningitis in a 60-year-old woman. The N. meningitidis strain was identified as serogroup B and sequence type (ST)-4893 by multilocus sequence typing (MLST). The patient in this case had visited France prior to development of symptoms. No meningococcal isolate belonging to ST-4893 has been identified in Japan previously, whereas an ST-4893 strain from France has been reported in the MLST database. These results strongly suggest that this case is likely to have been imported from France.

  23. 当院の血液培養におけるCandida属菌の分離状況と抗真菌薬感受性に関する臨床疫学的検討

    中山麻美, 右近紗緒里, 新谷知世, 濱岸真奈美, 池田貴和子, 和久田光毅, 細田卓也, 早川敏, 古川博, 石川隆志, 石井潤一

    愛知県臨床衛生検査技師会誌らぼ　61　(2)　2010

  24. Two cases of sepsis caused by Capnocytophaga spp.

    中山麻美, 濱岸真奈美, 新谷知世, 早川敏, 石井潤一, 都築基弘, 大楠清文

    医学検査　59　(10)　1171-1175　2010

    ISSN： 0915-8669

Show all ︎Show first 5

Misc. 4

  1. バイタルサインから血液培養検査陽性を予測する機械学習モデルの開発と検証

    清家 一生, 馬場 啓聡, 大島 健吾, 中山 麻美, 青柳 哲史

    日本感染症学会総会・学術講演会・日本化学療法学会学術集会合同学会プログラム・抄録集　100回・74回　O-089　2026/04

    Publisher: 日本感染症学会・日本化学療法学会

  2. クリプトコックス環境分離株の病原性の解析

    西田 朱里, 佐藤 光, 吉田 美智子, 中山 麻美, 菅野 恵美, 石井 恵子, 大楠 美佐子, 渡邉 哲, 石和田 稔彦, 川上 和義, 青柳 哲史

    日本感染症学会総会・学術講演会・日本化学療法学会学術集会合同学会プログラム・抄録集　100回・74回　O-171　2026/04

    Publisher: 日本感染症学会・日本化学療法学会

  3. 新規抗菌ペプチドCopW43誘導体の創薬と薬剤耐性菌に対する抗菌活性評価

    岡峯 真優, 坂本 泉, 權 垠相, 中山 麻美, 青柳 哲史, 鈴木 亜里紗, 西内 祐二, 佐藤 光

    日本感染症学会総会・学術講演会・日本化学療法学会学術集会合同学会プログラム・抄録集　100回・74回　O-241　2026/04

    Publisher: 日本感染症学会・日本化学療法学会

  4. 抗菌薬使用削減施策の追加実施によるカルバペネム系抗菌薬使用量の削減効果 国公立大学51施設観察研究

    加藤 英明, 千酌 浩樹, 上地 幸平, 鏡 圭介, 久保 有子, 潮平 英郎, 中出 順也, 中山 麻美, 仁木 誠, 高城 一郎, 濱田 洋平, 山本 剛, 岡田 直人, 堤 徳正

    日本感染症学会総会・学術講演会・日本化学療法学会学術集会合同学会プログラム・抄録集　100回・74回　O-289　2026/04

    Publisher: 日本感染症学会・日本化学療法学会

Books and Other Publications 16

  1. 今月の!検査室への質問に答えます･21 血液培養でグラム陰性球菌が陽性になったと言われました.何を想定して,どのように検査を進めるのか教えてください

    中山 麻美

    株式会社医学書院　2025/01/15

    DOI： 10.11477/mf.048514200690010106 　

  2. 臨床検査技師臨地実習ハンドブック

    市野, 直浩, 坂本, 秀生, 藤田, 孝, 直田, 健太郎, 南部, 重一, 山藤, 賢, 大澤, 佳代, 中根, 生弥, 大崎, 博之, 大沼, 健一郎, 井谷, 功典, 中山, 麻美, 野島, 順三, 中野, かおり, 常名, 政弘, 高崎, 昭彦, 細井, 英司, 大河戸, 光章, 松村, 充, 小松, 方, 泉, 礼司, 北川, 実美, 今井, 正 (臨床検査), 杉本, 邦彦

    医歯薬出版　2024/03

    ISBN: 9784263226995

  3. 技術講座 酵素基質培地の使いこなし方

    中山 麻美

    医歯薬出版　2024/02/15

    DOI： 10.32118/mt52020170 　

  4. 微生物検査 : 迅速・培養検査—チェックリストで見直す 検査と医療関連感染対策 ; 平時の検査業務における医療関連感染対策の実際

    中山 麻美

    東京 : 医学書院　2023/04

    DOI： 10.11477/mf.1542203270 　

  5. 技術講座 微生物 発色酵素基質培地の基本

    中山 麻美

    株式会社医学書院　2022/12/01

    DOI： 10.11477/mf.1543208852 　

  6. 増刊号 First＆Next Step 微生物検査サポートブック 各論 菌種別の培養･同定方法 グラム陰性球菌 淋菌-Neisseria gonorrhoeae

    中山 麻美

    株式会社医学書院　2021/03/15

    DOI： 10.11477/mf.1543208292 　

  7. 増刊号 First＆Next Step 微生物検査サポートブック 各論 菌種別の培養･同定方法 グラム陰性球菌 カタル球菌-Moraxella catarrhalis

    中山 麻美

    株式会社医学書院　2021/03/15

    DOI： 10.11477/mf.1543208291 　

  8. 増刊号 First＆Next Step 微生物検査サポートブック 各論 菌種別の培養･同定方法 グラム陰性球菌 髄膜炎菌-Neisseria meningitidis

    中山 麻美

    株式会社医学書院　2021/03/15

    DOI： 10.11477/mf.1543208293 　

  9. 臨床検査のピットフォール Neisseria meningitidisの同定-非病原性Neisseria属菌との鑑別

    中山 麻美

    株式会社医学書院　2021/01/01

    DOI： 10.11477/mf.1543208237 　

  10. 増刊号 感染症クイックリファレンス 原因微生物 グラム陰性球菌 Moraxella catarrhalis

    中山 麻美

    株式会社医学書院　2018/03/15

    DOI： 10.11477/mf.1543207084 　

  11. 増刊号 感染症クイックリファレンス 原因微生物 グラム陽性桿菌 Listeria monocytogenes

    中山 麻美

    株式会社医学書院　2018/03/15

    DOI： 10.11477/mf.1543207081 　

  12. 増刊号 感染症クイックリファレンス 原因微生物 グラム陽性桿菌 Nocardia spp.

    中山 麻美

    株式会社医学書院　2018/03/15

    DOI： 10.11477/mf.1543207082 　

  13. 増刊号 感染症クイックリファレンス 原因微生物 グラム陰性球菌 Neisseria gonorrhoeae

    中山 麻美

    株式会社医学書院　2018/03/15

    DOI： 10.11477/mf.1543207083 　

  14. 増刊号 感染症クイックリファレンス 原因微生物 グラム陰性桿菌 Haemophilus influenzae

    中山 麻美

    株式会社医学書院　2018/03/15

    DOI： 10.11477/mf.1543207085 　

  15. 増刊号 感染症クイックリファレンス 原因微生物 グラム陰性桿菌 Legionella pneumophila

    中山 麻美

    株式会社医学書院　2018/03/15

    DOI： 10.11477/mf.1543207086 　

  16. The healthcare-associated infection control in cooperation with healthcare facilities in the region

    2015/04/15

    DOI： 10.11477/mf.1542200288 　

Show all Show first 5

Presentations 52

  1. 酸化鉄ナノ粒子を基盤とした経鼻肺炎球菌ワクチンの開発と標的cladeの検討

    能代 咲花, 佐藤 光, 中山 麻美, 大島 健吾, 菅野 恵美, 石井 恵子, 川上 和義, 青柳 哲史

    日本感染症学会総会・学術講演会・日本化学療法学会学術集会合同学会プログラム・抄録集　2026/04

  2. バイタルサインから血液培養検査陽性を予測する機械学習モデルの開発と検証

    清家 一生, 馬場 啓聡, 大島 健吾, 中山 麻美, 青柳 哲史

    日本感染症学会総会・学術講演会・日本化学療法学会学術集会合同学会プログラム・抄録集　2026/04

  3. クリプトコックス環境分離株の病原性の解析

    西田 朱里, 佐藤 光, 吉田 美智子, 中山 麻美, 菅野 恵美, 石井 恵子, 大楠 美佐子, 渡邉 哲, 石和田 稔彦, 川上 和義, 青柳 哲史

    日本感染症学会総会・学術講演会・日本化学療法学会学術集会合同学会プログラム・抄録集　2026/04

  4. 新規抗菌ペプチドCopW43誘導体の創薬と薬剤耐性菌に対する抗菌活性評価

    岡峯 真優, 坂本 泉, 權 垠相, 中山 麻美, 青柳 哲史, 鈴木 亜里紗, 西内 祐二, 佐藤 光

    日本感染症学会総会・学術講演会・日本化学療法学会学術集会合同学会プログラム・抄録集　2026/04

  5. 抗菌薬使用削減施策の追加実施によるカルバペネム系抗菌薬使用量の削減効果 国公立大学51施設観察研究

    加藤 英明, 千酌 浩樹, 上地 幸平, 鏡 圭介, 久保 有子, 潮平 英郎, 中出 順也, 中山 麻美, 仁木 誠, 高城 一郎, 濱田 洋平, 山本 剛, 岡田 直人, 堤 徳正

    日本感染症学会総会・学術講演会・日本化学療法学会学術集会合同学会プログラム・抄録集　2026/04

  6. 広範な病変を呈した播種性皮膚Mycobacterium chelonae感染症の1例

    大藪 公平, 馬場 啓聡, 粟田 潤, 清家 一生, 北村 知穂, 武井 健太郎, 中山 麻美, 大島 謙吾, 青柳 哲史

    感染症学雑誌　2026/01

  7. 臨床と微生物検査技師との連携についての事例 東北大学病院における臨床(医)と微生物検査(師)との連携事例 NICU監視培養検査体制の整備

    中山 麻美

    日本臨床微生物学会雑誌　2025/12

  8. MALDI-TOF質量分析とClinProToolsを組み合わせた毒素産生性Clostridioides difficileの迅速検出の評価(Evaluation of MALDI-TOF mass spectrometry coupled with ClinProTools as a rapid tool for toxin-producing Clostridioides difficile)

    中山 麻美

    日本臨床微生物学会雑誌　2025/12

  9. 外科/救急領域における感染症迅速診断法の活用 質量分析

    中山 麻美

    日本外科感染症学会雑誌　2025/10

  10. 抗HIV治療により寛解に至ったAIDS合併潰瘍性大腸炎の一例

    粟田 潤, 馬場 啓聡, 清家 一生, 中山 麻美, 北村 知穂, 武井 健太郎, 大島 謙吾, 青柳 哲史

    日本感染症学会総会・学術講演会・日本化学療法学会学術集会合同学会プログラム・抄録集　2025/04

  11. 抗酸菌培養検査体制の再構築

    石戸谷 真帆, 大杉 悠平, 星 啓太, 佐藤 亜耶, 木村 裕子, 佐藤 敦子, 千葉 美紀子, 中山 麻美, 勝見 真琴, 菅原 新吾

    日本臨床微生物学会雑誌　2024/12

  12. 血液培養遺伝子検査導入による抗MRSA薬使用の適正化と臨床的効果

    千葉 美紀子, 中山 麻美, 石戸谷 真帆, 木村 裕子, 大杉 悠平, 星 啓太, 佐藤 敦子, 勝見 真琴, 菅原 新吾, 青柳 哲史

    日本臨床微生物学会雑誌　2024/12

  13. FilmArray血液培養パネル2を用いた遺伝子検査の効果と検査体制の構築

    千葉美紀子, 中山麻美, 佐藤亜耶, 佐藤敦子, 佐々木克幸, 勝見真琴, 阿部裕子, 藤巻慎一

    日本医学検査学会(Web)　2024

  14. POT検査を用いたMRSA院内伝播検知と感染経路特定の有効性に関する報告

    千葉美紀子, 中山麻美, 佐藤亜耶, 佐々木克幸, 石戸谷真帆, 勝見真琴, 鈴木千恵, 菅原新吾

    日臨技北日本支部医学検査学会(Web)　2024

  15. フーリエ変換赤外線分光法(FT-IR)を活用した事例紹介

    中山麻美

    日本環境感染学会総会・学術集会 シンポジウム　2023/07/22

  16. 当院における喀痰洗浄培養導入に向けた取り組み

    星啓太, 三浦悠理子, 大杉悠平, 佐藤亜耶, 中山麻美, 勝見真琴, 阿部裕子, 藤巻慎一

    日本医学検査学会(Web)　2023

  17. 「コバス5800システム」を用いた結核菌群およびMycobacterium avium complex(MAC)検出の検討

    石戸谷真帆, 千葉美紀子, 中山麻美, 勝見真琴, 阿部裕子, 藤巻慎一

    医療検査と自動化(Web)　2023

  18. 新型コロナウイルスとLegionella pneumophilaの共感染による重症肺炎で太平洋上の貨物船から医療搬送された一例

    北谷栞, 北谷栞, 馬場啓聡, 大島謙吾, 武井健太郎, 清家一生, 徳田浩一, 中山麻美, 金森肇

    日本感染症学会総会・学術講演会・日本化学療法学会学術集会合同学会プログラム・抄録集(CD-ROM)　2023

  19. 血液培養検査における遺伝子検査体制構築へ向けたアンケート調査結果

    佐藤亜耶, 千葉美紀子, 石戸谷真帆, 佐々木克幸, 中山麻美, 勝見真琴, 阿部裕子, 藤巻慎一

    日臨技北日本支部医学検査学会(Web)　2023

  20. 当院の新型コロナウイルス変異株の検出状況および感染性リスク評価における発症日とCt値の関連性

    中山麻美, 岡本道子, 馬場啓聡, 金森肇, 押谷仁

    日本感染症学会東日本地方会学術集会・日本化学療法学会東日本支部総会合同学会プログラム・抄録集　2022

  21. 夜間休日検査室におけるSARS-CoV-2不活化試薬を用いた新型コロナウイルスPCR検査体制の構築

    中山麻美, 鈴木千恵, 武田卓也, 高橋昇之, 三浦悠理子, 勝見真琴, 阿部裕子, 藤巻慎一, 藤原亨

    医療検査と自動化(Web)　2021

  22. 血液培養装置BACT/ALERT VIRTUOの陽性検知能における有用性

    千葉美紀子, 中山麻美, 石澤千幸, 三浦悠理子, 佐藤敦子, 星啓太, 佐藤貴美, 勝見真琴, 阿部裕子, 藤巻慎一, 藤原亨

    医療検査と自動化(Web)　2021

  23. 新規超高速PCR機器GeneSoCの鼻腔MRSA検出性能の評価

    千葉美紀子, 青柳哲史, 中山麻美, 勝見真琴, 藤巻慎一, 藤原亨, 吉田眞紀子, 賀来満夫

    医療検査と自動化(Web)　2021

  24. POT(PCR-based ORF typing)における各種電気泳動の比較検討

    佐藤貴美, 中山麻美, 千葉美紀子, 勝見真琴, 阿部裕子, 藤巻慎一, 藤原亨

    医療検査と自動化(Web)　2021

  25. MALDI-TOF MSを用いたClostridioides difficileトキシン産生株の識別能の評価

    中山麻美, 中山麻美, 森永芳智, 賀来敬仁, 森兼啓太, 柳原克紀

    日本感染症学会西日本地方会学術集会・日本感染症学会中日本地方会学術集会・日本化学療法学会西日本支部総会合同開催プログラム・抄録集　2021

  26. Strep B Carrot Broth「ニッスイ」を用いた迅速かつ効率的な妊婦GBSスクリーニング検査体制の構築

    三浦悠理子, 中山麻美, 石澤千幸, 千葉美紀子, 佐藤敦子, 星啓太, 高橋昇之, 勝見真琴, 藤巻慎一

    臨床微生物迅速診断研究会総会プログラム・抄録集　2021

  27. 抗菌薬適正使用支援チームにおける臨床微生物検査技師の役割【抄録】

    中山麻美, 中山麻美, 鈴木祥子, 東海林佳兼, 東海林佳兼, 森兼啓太, 森兼啓太

    臨床病理　2020

  28. 抗菌薬適正使用支援チームにおける臨床微生物検査技師の役割

    中山麻美, 中山麻美, 鈴木祥子, 東海林佳兼, 東海林佳兼, 森兼啓太, 森兼啓太

    第51回日本臨床検査医学会東北支部総会　2019/07/27

  29. Mass Spectrometry

    中山麻美

    日本外科感染症学会雑誌(Web)　2020

  30. 薬剤耐性アシネトバクター制御に向けた伝播対策の取り組み

    鈴木祥子, 中山麻美, 森兼啓太

    日本環境感染学会総会・学術集会(Web)　2020

  31. Clostridioides difficile感染症診療における検査体制の評価とNAAT導入に向けた検討

    中山麻美, 森永芳智, 賀来敬仁, 森兼啓太, 柳原克紀

    日本感染症学会西日本地方会学術集会・日本感染症学会中日本地方会学術集会・日本化学療法学会西日本支部総会合同開催プログラム・抄録集　2020

  32. Clostridioides difficileの分離株の病原遺伝子保有状況と臨床的解析

    中山麻美, 中山麻美, 森永芳智, 賀来敬仁, 森兼啓太, 柳原克紀

    日本感染症学会西日本地方会学術集会・日本感染症学会中日本地方会学術集会・日本化学療法学会西日本支部総会合同開催プログラム・抄録集　2019

  33. 血清型B群,遺伝子型ST-687の髄膜炎菌による敗血症の1例

    伊豆野良太, 中山麻美, 早乙女綾子, 工藤慎也, 白田亨, 森兼啓太

    日本医学検査学会(Web)　2019

  34. カルバペネム系抗菌薬投与患者における抗菌薬監視体制の臨床アウトカム評価

    藤林彩里, 丹羽隆, 丹羽隆, 竹市朱里, 竹市朱里, 鈴木景子, 鈴木景子, 太田浩敏, 中山麻美, 土屋真由美, 畠山大二郎, 鈴木昭夫, 村上啓雄, 伊藤善規

    日本医療薬学会年会講演要旨集(Web)　2017

  35. 抗真菌薬注射剤が投与された全患者への適正使用介入による臨床アウトカム評価

    竹市朱里, 竹市朱里, 丹羽隆, 丹羽隆, 鈴木景子, 鈴木景子, 藤林彩里, 太田浩敏, 中山麻美, 土屋真由美, 山本昌代, 畠山大二郎, 鈴木昭夫, 村上啓雄, 伊藤善規

    日本医療薬学会年会講演要旨集(Web)　2017

  36. 質量分析法の特徴を生かす日常検査のワークフロー構築についての検討

    米玉利準, 中山麻美, 白井菜月, 丹羽麻由美, 伊藤彰洋, 太田浩敏, 古田伸行, 渡邉珠代, 伊藤弘康, 村上啓雄, 清島満

    臨床微生物迅速診断研究会総会プログラム・抄録集　2015

  37. 当院におけるPOT法を用いたMRSAの分子疫学解析

    米玉利準, 太田浩敏, 太田浩敏, 中山麻美, 中山麻美, 白井菜月, 丹羽麻由美, 伊藤彰洋, 丹羽隆, 土屋麻由美, 古田伸行, 渡邉珠代, 伊藤弘康, 村上啓雄, 清島満

    臨床病理　2015

  38. LAMP法を用いた結核菌群遺伝子検査の院内導入に向けた検討・評価

    中山麻美, 米玉利準, 丹羽麻由美, 伊藤彰洋, 太田浩敏, 古田伸行, 伊藤弘康, 清島満

    臨床病理　2015

  39. 全注射用抗菌薬の監視体制による血液培養陽性症例の臨床効果の改善

    丹羽隆, 丹羽隆, 渡邉珠代, 後藤貴之, 太田浩敏, 中山麻美, 鈴木景子, 土屋麻由美, 安田浩二, 村上啓雄, 伊藤善規

    日本医療薬学会年会講演要旨集　2015

  40. 全自動塗布装置の基礎的検討

    太田浩敏, 中山麻美, 米玉利準, 古田伸行, 伊藤弘康, 清島満

    日本臨床検査自動化学会会誌　2014

  41. 血液培養よりBrachyspira pilosicoliが検出された1症例

    犬飼ともみ, 松井奈津子, 加藤礼子, 藏前仁, 伊藤誠, 大楠清文, 中山麻美

    日本臨床微生物学雑誌　2014

  42. 急性心筋梗塞による機械的合併症の心エコー診断と予後

    曽根希信, 岩瀬正嗣, 高桑蓉子, 椎野憲二, 高田佳代子, 伊藤義浩, 高橋礼子, 小川歩, 中山麻美, 尾崎行男

    超音波医学　2013

  43. Mycobacterium chelonaeによる角膜炎の1例

    宮崎崇, 大瀧博文, 中山麻美, 米玉利準, 安藤航平, 太田浩敏, 古田伸行, 伊藤弘康, 伊藤弘康, 望月清文, 清島満, 清島満

    臨床病理　2013

  44. 急性心筋梗塞による機械的合併症の心エコー診断と予後

    曽根希信, 高桑蓉子, 椎野憲二, 高田佳代子, 伊藤義活, 尾崎行男, 高木靖, 安藤太三, 中山麻美, 高橋礼子, 岩瀬正嗣

    日本心エコー図学会学術集会抄録集　2013

  45. 入院後から徐々に循環動態の悪化を認め,PCPSを挿入した劇症型心筋炎症例が,徐々に心機能の改善をきたし,救命しえた症例

    高田佳代子, 椎野憲二, 曽根希信, 高橋礼子, 中山麻美, 岩瀬正嗣, 尾崎行男

    日本心エコー図学会学術集会抄録集　2013

  46. 当院総合救命救急センターにおける血液培養採取による診療支援体制の構築

    中山麻美, 早川敏

    日本臨床微生物学雑誌　2012

  47. 救命センターにおけるプロカルシトニン測定の有用性(全身性反応症候群と敗血症診断との関連性)

    武田淳, 北川文彦, 中山麻美, 久野貴弘, 齊藤翠, 近藤文子, 藤田孝, 石川隆志, 石井潤一

    日本臨床検査自動化学会会誌　2012

  48. 血液培養システムVersa TREKにおける菌検出時間の検討

    早川敏, 細田卓也, 東本祐紀, 池田貴和子, 濱岸真奈美, 新谷知世, 右近紗緒里, 中山麻美

    日本臨床微生物学雑誌　2010

  49. 血液培養より分離されたCandida属と(1→3)-β-Dグルカンの関連性について

    新谷知世, 濱岸真奈美, 中山麻美, 右近紗緒里, 早川敏, 古川博, 石川隆志, 石井潤一

    医学検査　2010

  50. 海外渡航先での感染/保菌が示唆された髄膜炎菌感染症の1例

    中山麻美, 早川敏, 濱岸真奈美, 池田貴和子, 新谷知世, 大楠清文

    日本臨床微生物学雑誌　2009

  51. 当院における血液培養検出菌について

    新谷知世, 早川敏, 池田貴和子, 濱岸真奈美, 和久田光毅, 久野由紀子, 中山麻美, 細井光沙, 右近紗緒里, 古川博, 石井潤一

    愛知県臨床衛生検査技師会誌らぼ　2009

  52. マイクロスキャンRapidパネルを用いた,血液培養陽性ボトルからの直接法の検討

    中山麻美, 早川敏, 濱岸真奈美, 池田貴和子

    日本臨床微生物学雑誌　2008

Show all Show first 5

Research Projects 2

  1. 質量分析とOne Healthアプローチを活用したC. difficile感染症の統合的予防戦略の構築

    中山 麻美

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 若手研究

    Institution: 東北大学

    2026/04/01 - 2029/03/31

  2. MALDI-TOF MSを使用したC. difficile毒素検出モデルの有用性・分子疫学解析への応用

    中山 麻美

    Offer Organization: 日本学術振興会

    System: 科学研究費助成事業

    Category: 奨励研究

    Institution: 東北大学

    2025/04/01 - 2026/03/31